Citation Impact

Citing Papers

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Untangling the ErbB signalling network
2001 Standout
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
2009
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
1994
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
1996 Science
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients
2001
Regulation of signal transduction by endocytosis
2000
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cells
1995
Prognostic Factors in Breast Cancer
2000
Thyroid cancer
2016 Standout
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology
1995
Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung
2001
How Tumors Become Angiogenic
1996
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Hypoxia-mediated stimulation of carcinoma cell invasivenessvia upregulation of urokinase receptor expression
1999
Cellular senescence: when bad things happen to good cells
2007 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1995
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
1998
The Thyroid Nodule
2004 Standout
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
2004
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
1998
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Stimulation of Plasminogen Activator Inhibitor-1 Expression in Immortalized Human Trophoblast Cells Cultured under Low Levels of Oxygen
1998
Improved biochemical strategies for targeted delivery of taxoids
2007
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Hallmarks of Cancer
2000 Standout
Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome
2000
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Angiogenesis in health and disease
2003 Standout
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
2002
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Systematic Mutational Analysis of the Receptor‐Binding Region of the Human Urokinase‐Type Plasminogen Activator
1996
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers
2003
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
1995
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Autonomy in Endemic Goiter
1998
Levels of Hypoxia-Inducible Factor-1  During Breast Carcinogenesis
2001 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
Immunity, Inflammation, and Cancer
2010 Standout
Male breast cancer
2006 Standout
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
1995
Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry
2001
Differential regulation of urokinase-type-1 inhibitor complex endocytosis by phorbol esters in different cell lines is associated with differential regulation of α2-macroglobulin receptor and urokinase receptor expression
1995
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Genetic alterations in breast cancer
1995
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice
2004
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Microenvironmental regulation of metastasis
2008 Standout
Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions
2010
Iodine-deficiency disorders
2008 Standout
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Status of HER-2 in male and female breast carcinoma
2001
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
1995
Molecular genetics and diagnosis of thyroid cancer
2011
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.
1996
Cancer-related inflammation
2008 StandoutNature
Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomas
1996
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
2004
The fundamental role of epigenetic events in cancer
2002 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Src-dependent Tyrosine Phosphorylation Regulates Dynamin Self-assembly and Ligand-induced Endocytosis of the Epidermal Growth Factor Receptor
2002 StandoutNobel
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites
2003
Matrix Metalloproteinases
1999 Standout
The multiple roles of tumour stroma
1997
Molecular Alterations in Partially-Encapsulated or Well-Circumscribed Follicular Variant of Papillary Thyroid Carcinoma
2013
Regulation of Integrin Function by the Urokinase Receptor
1996 Science
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Serpin Structure, Mechanism, and Function
2002 Standout
Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression
2003
Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
2001
Functional rafts in cell membranes
1997 StandoutNature
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Mass spectrometry-based proteomics
2003 StandoutNature
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.
1995
Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells
1999
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
1994
Papillary Thyroid Carcinoma Associated with Papillary Renal Neoplasia: Genetic Linkage Analysis of a Distinct Heritable Tumor Syndrome*
2000
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.
1995
The urokinase receptor
1994
Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
1994
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
1996
The Urokinase Receptor. Protein Structure and Role in Plasminogen Activation and Cancer Invasion
1995
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Evaluation and Management of the Solid Thyroid Nodule
1995
Construction and Validation of Improved Triple Fusion Reporter Gene Vectors for Molecular Imaging of Living Subjects
2007 StandoutNobel

Works of Ann Thor being referenced

The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
1992
RasOncogene Mutations in Benign and Malignant Thyroid Neoplasms
1991
Immunohistochemical localization of the plasminogen activator inhibitor‐1 in breast cancer
1995
Loss of heterozygosity and p53 gene mutations in breast cancer.
1994
ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.
1986
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue.
1994
Rankless by CCL
2026